PCR tests at Frankfurt Airport: CENTOGENE and Lufthansa take positive balance at the end of the summer vacations

With the faculty get started in Baden-Wuerttemberg the summer season vacation year finishes in total Germany. At the finish of the summer season, CENTOGENE and Lufthansa are having a constructive interim balance of the check centers at German airports. Considering the fact that the finish of June, the companions have been jointly enabling passengers departing from or arriving at Frankfurt Airport (FRA), as very well as those from the location, to have access to rapidly, responsible assessments for the SARS CoV-2 virus. This 1st “walk-in” coronavirus check center in Germany serves as a blueprint for a successful check principle and will help passengers getting into Germany from large-chance international locations.

In the summer season of 2020, extra than a hundred and fifty,000 passengers were being examined at Frankfurt Airport using CENTOGENE’s remarkably delicate SARS-CoV-2 PCR check. On normal, about a person per cent of the samples were being constructive through the very last 6 weeks. More than 97 per cent of the COVID-19 check results were being digitally transmitted to passengers in August 2020 in less than 24 hrs. Travellers who had registered for the check in advance only had to wait approx. 20 minutes right before getting examined. Most of them arrived from Spain, followed by the United states of america, Turkey and Croatia. In addition, practically fifty,000 passengers were being examined right before departure, for illustration to vacation to China or Dubai, wherever a detrimental check consequence is required for entry. The basic populace from the location also utilized the check center. Considering the fact that mid-August, another check center has also been in operation at Hamburg Airport.

Most a short while ago, the screening potential at the check center at Frankfurt has been expanded and the sampling area has been enlarged to give a hassle-free solution for vacationers. The check center in Frankfurt now has a potential of all-around ten,000 assessments per working day, which is extra than adequate even at times of large demand from customers. On normal, all-around 4,five hundred assessments per working day were being carried out in the summer season months of July and August. The CENTOGENE assistance complements the present general public laboratory capacities of the wellness care technique and relieves them.

Lufthansa Group passengers can now also use the rapidly lane at the CENTOGENE check center at Frankfurt Airport and thus continue to keep ready times to a bare minimum. Special rapidly lanes are also accessible for Lufthansa Group status prospects, business and 1st course travellers.

“It is appropriate that the screening strategy for travellers from large-chance international locations will be preserved in September. As an alternative of abolishing the assessments from Oct and dismantling the successfully proven screening infrastructure at airports, the present screening capacities should be even more expanded and utilized even extra extensively. The knowledge obtained from the assessments can make a considerable contribution to reacting to the current an infection problem with specific and ideal actions. The cooperation between Lufthansa and CENTOGENE, which is continually increasing its capacities, serves as a benchmark for a successful check design listed here,” claims Christina Foerster, Lufthansa Group Buyer, IT & Company Responsibility Board Member.

Dr. Volkmar Weckesser, CIO CENTOGENE, emphasizes: “We firmly consider that wide-primarily based screening is the key to stopping a even more outbreak and supporting a new ordinary – in particular wherever mobility is an crucial contribution to the performance of our economic climate. This is why we have released economical, electronic workflows for COVID-19 screening at two of Germany’s largest airports. We are certainly convinced that this choice is appropriate and will hence proceed to drastically boost our screening capacities. In this way, we can make an critical contribution to the screening infrastructure – also for professional medical staff or the populace in the location. Earlier mentioned all, many thanks to the hottest know-how and innovation, we are also doing work intensively on new, faster check techniques. 

Travellers can execute the check in a sample selection center in the instant vicinity of the principal terminal of Frankfurt Airport. All results are made accessible to passengers by way of a safe electronic system and linked to the flight ticket to be certain automated confirmation for vacationers traveling to international locations with respective entry constraints. In addition, passengers can decide on an id confirmation assistance that certifies authorities that the check results match the passengers’ id.

About CENTOGENE
CENTOGENE engages in diagnosis and exploration all-around rare disorders reworking real-globe scientific and genetic knowledge into actionable info for sufferers, medical professionals, and pharmaceutical organizations. Our goal is to provide rationality to procedure selections and to speed up the improvement of new orphan medicines by using our considerable rare condition understanding, which include epidemiological and scientific knowledge, as very well as innovative biomarkers. CENTOGENE has created a global proprietary rare condition system primarily based on our real-globe knowledge repository with approximately 3. billion weighted knowledge factors from more than 530,000 sufferers symbolizing more than one hundred twenty unique international locations as of March 31, 2020.
The Company’s system includes epidemiologic, phenotypic, and genetic knowledge that demonstrates a global populace, and also a biobank of these patients’ blood samples. CENTOGENE believes this signifies the only system that comprehensively analyzes multi-degree knowledge to boost the being familiar with of rare hereditary disorders, which can aid in the identification of sufferers and boost our pharmaceutical partners’ means to provide orphan medicines to the marketplace. As of March 31, 2020, the Organization collaborated with 39 pharmaceutical companions masking more than 45 unique rare disorders.